0940-05-42-.11
Individualized Treatment Plan
Cite as Tenn. Comp. R. & Regs. 0940-05-42-.11
(1)
A Facility shall develop an Individualized Treatment Plan (ITP) for each service recipient
within thirty (30) days of admission. Each service recipient shall be involved in the
development and review of their ITP. The initial ITP and all reviews shall be signed, either in
person, electronically, or by documented verbal acknowledgement, by the service recipient,
qualified counseling provider, and program provider. ITPs shall document the following:
(a)
A consistent pattern of substance use treatment services and medical care appropriate
to the individual service recipient’s needs; and
(b)
S.M.A.R.T. goals discussed and agreed upon by the qualified counseling provider,
program provider and the service recipient. The Facility may use alternative treatment
planning methods provided that the methodology is evidence-based and provides
similar details to those of the S.M.A.R.T. goals as defined by these rules.
(2)
The admission requirements of Rule 0940-05-42-.06 shall be completed prior to the
development of an ITP.
(3)
Medical care, including referral for necessary medical service, and evaluation and follow-up
of service recipient complaints shall be compatible with current and accepted standards of
medical practice. All service recipients shall receive a physical examination at least annually.
All other medical procedures performed at the time of admission shall be reviewed by the
medical staff on an annual basis, and all clinically indicated tests and procedures shall be
repeated. The medical director or program provider shall record the results of the annual
medical examination and review of service recipient medical records in each service
recipient’s medical record.
(4)
In recognition of the varied medical needs of service recipients, any case histories, ITPs,
short-term withdrawal management plans, and discharge plans shall be reviewed at least
every ninety (90) days for service recipients in treatment less than one (1) year and at least
every six (6) months for service recipients in treatment more than one (1) year. This review
will be conducted by the medical director or program provider along with the primary qualified
counseling provider and other appropriate members of the treatment team involved in the
service recipient’s treatment. This review shall also include an assessment of the current
dosage, schedule, and the rehabilitative progress of the individual, as part of a determination
that additional medical services are indicated. If this review results in a determination that
additional or different medical or behavioral health services are indicated, the Facility shall
ensure that such services are made available to the service recipient, either at the Facility or
by referral to the appropriate medical professional. Any referrals shall be documented in the
service recipient’s medical record and followed up on as appropriate.
(5)
When the program provider prescribes other controlled substances to service recipients in
the Facility, the Facility shall ensure that such prescription is in compliance with all applicable
statutes and regulations and with current and accepted standards of medical practice. Such
prescriptions shall not be issued to any service recipient unless the program provider first
sees the service recipient and assesses the service recipient’s potential for misuse of such
medications.
MINIMUM PROGRAM REQUIREMENTS FOR NON-RESIDENTIAL
CHAPTER 0940-05-42
OPIOD TREATMENT PROGRAM FACILITIES
(6)
As part of the rehabilitative services provided by the Facility, each service recipient shall be
provided with individual and group counseling appropriate to their needs. The frequency and
duration of counseling provided to service recipients shall be in conformity with Rule 0940-
05-42-.14 and be consistent with the ITP. ITPs shall indicate a specific level of counseling
services needed by the service recipient as part of the rehabilitative process.
(7)
All service recipients shall receive HIV and hepatitis risk reduction education appropriate to
their needs.
(8)
When appropriate, the Facility shall provide each service recipient information regarding
enrollment in a vocational education program, engaging in a vocational activity (vocational
evaluation, education, or skill training), or assisting the service recipient in efforts to seek
gainful employment. Deviations from compliance with these requirements shall be explained
in the service recipient’s medical record. Each Facility shall take steps to ensure that a
comprehensive range of rehabilitative services, including vocational, educational, legal,
mental health, treatment for other substances of misuse, and social services, are made
available to the service recipients who demonstrate a need for such services. The Facility
can fulfill this responsibility by providing support services directly or by appropriate referral.
Support service(s) recommended and utilized shall be documented in the service recipient’s
medical record.
(9)
All Facilities will develop and implement policies for matching service recipient’s needs to
treatment. These policies may include treatment phasing in which the intensity of medical,
counseling, and rehabilitative services provided to a service recipient is individualized for
each service recipient depending upon the service recipient’s phase of treatment.
(10) If the service recipient experiences a return to drug use, their ITP shall document evidence of
intensified services. Such evidence shall include, but is not limited to, an increase in
individual or group counseling session(s) and a reduction in the service recipient’s take-home
privileges.
(11) The program providers shall initiate and lead a discussion regarding patient readiness to
taper down or taper off treatment medications employed in the patient’s treatment with each
patient no later than one (1) year after initiating treatment and then every six (6) months
thereafter or at any time upon the patient’s request. Documentation of this discussion shall be
included in the patient’s ITP. Nothing in this part shall be construed to mean that patients
should be forced to taper down or off of treatment medications.